Gastroenterology and Hepatology - GI Malignancies: An Evidence-Based Approach to Screening, Surveillance, Genetic Testing, and Prevention
American College of Physicians View Cart
American College of Physicians
Home Events Webcasts Topics Presenters Specials Help
Search:  

Current Topics

Formats: MP3, CD, iPod Audio, AudioPoint for Computer and iPod
Pre-Course Sessions
Additional Topics
Associates, Residents and Fellows in Training
Cardiology
Career and Professionalism
Clinical Pearls
Clinical Pharmacology
Endocrinology
End-of-Life and Palliative Care
Ethics and Health Policy
Gastroenterology and Hepatology
Geriatric Medicine
Health Information Technology
Hematology
Hospital Medicine
Infectious Diseases
Medical Practice Management
Medical Student Programs
Multiple Small Feedings of the Mind
Nephrology and Hypertension
Neurology
Oncology
Ophthalmology and Otolaryngology
Perioperative Medicine
Psychiatry
Pulmonary Diseases and Critical Care
Rheumatology and Allergy & Immunology
Updates
Women's Health

Gastroenterology and Hepatology


GI Malignancies: An Evidence-Based Approach to Screening, Surveillance, Genetic Testing, and Prevention

Session #: 850-160
Presenter(s): Brooks D. Cash, MD, MC, USN, CDR, FACP; Roy K. H. Wong, Col., MD; Walter J. Coyle, FACG, MD, FACP
Session Length: 1 hr. 30 min.
Event: Internal Medicine 2010
Date: April 22-24, 2010


Purchase Media - Session #: 850-160
Description Price Qty. Cart
 Audio CD $17.95 buy now  
 MP3 CD-ROM $17.95 buy now  
 iPod Audiobook CD-ROM $17.95 buy now  
 AudioPoint for your computer $24.95 buy now  
 AudioPoint for your iPod $24.95 buy now  
 Download MP3 & iTunes Audiobook File $17.95
buy now  
 Download AudioPoint for iPod $24.95
buy now  

PN 032
GI Malignancies: An Evidence-Based Approach to Screening, Surveillance, Genetic Testing, and Prevention

Clinical questions to be addressed:

  1. What is the evidence-based approach to surveillance for colorectal cancer (e.g. Colonoscopy, Virtual CT, fecal DNA)?
  2. What are the new genetic links in GI cancers?
  3. Who should be tested for genetic predisposition for pancreatic or colon cancer? Is there good evidence?
  4. Are we ready for pancreatic cancer screening? Who should be screened?
  5. Is screening and surveillance for Barrett's esophagus a cost effective strategy?
  6. Is there evidence to support ablation of Barrett's mucosa?
  7. Are we ready for DNA analysis of the esophagus?




Conference Recordings  |   Contact Us  |   FAQ   |   Order Process  |   Privacy Policy  |   Shipping Policy  |   Your Account  |  Login  |   View Cart
© Copyright 2006 iPlayback. All Rights Reserved.
Developed in and hosted by CommerceV3.